1. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017; :. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  2. Tantayakom, P, Koolvisoot, A, Arromdee, E, Chiowchanwisawakit, P, Muangchan, C, Katchamart, W et al.. Metabolic syndrome is associated with disease activity in patients with rheumatoid arthritis. Joint Bone Spine. 2016;83 (5):563-7. doi: 10.1016/j.jbspin.2015.10.016. PubMed PMID:27238198 .
  3. Muangchan, C, Pope, JE. Reply. Arthritis Care Res (Hoboken). 2016;68 (9):1385-6. doi: 10.1002/acr.22851. PubMed PMID:26814437 .
  4. Pope, JE, Rothfield, NF, Ramsey-Goldman, R, Douglas Smith, C, Bernatsky, SR, Furie, RA et al.. Reply. Arthritis Care Res (Hoboken). 2016;68 (7):1053-4. doi: 10.1002/acr.22777. PubMed PMID:26555102 .
  5. Muangchan, C, van Vollenhoven, RF, Bernatsky, SR, Smith, CD, Hudson, M, Inanç, M et al.. Treatment Algorithms in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2015;67 (9):1237-45. doi: 10.1002/acr.22589. PubMed PMID:25777803 .
  6. Lee, J, Peschken, CA, Muangchan, C, Silverman, E, Pineau, C, Smith, CD et al.. The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort. Lupus. 2013;22 (13):1341-8. doi: 10.1177/0961203313505689. PubMed PMID:24048215 .
  7. Muangchan, C, Canadian Scleroderma Research Group, Baron, M, Pope, J. The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review. J. Rheumatol. 2013;40 (9):1545-56. doi: 10.3899/jrheum.121380. PubMed PMID:23858045 .
  8. Mansour, S, Bonner, A, Muangchan, C, Hudson, M, Baron, M, Pope, JE et al.. Low socioeconomic status (measured by education) and outcomes in systemic sclerosis: data from the Canadian Scleroderma Research Group. J. Rheumatol. 2013;40 (4):447-54. doi: 10.3899/jrheum.120570. PubMed PMID:23418377 .
  9. Muangchan, C, Harding, S, Khimdas, S, Bonner, A, Canadian Scleroderma Research group, Baron, M et al.. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group. Arthritis Care Res (Hoboken). 2012;64 (9):1405-14. doi: 10.1002/acr.21716. PubMed PMID:22556030 .
  10. Muangchan, C, Pope, JE. Interleukin 6 in systemic sclerosis and potential implications for targeted therapy. J. Rheumatol. 2012;39 (6):1120-4. doi: 10.3899/jrheum.111423. PubMed PMID:22505699 .
  11. Muangchan, C, Nilganuwong, S. The study of clinical manifestation of osteoarticular tuberculosis in Siriraj Hospital, Thailand. J Med Assoc Thai. 2009;92 Suppl 2 :S101-9. . PubMed PMID:19562993 .
Search PubMed